Medimaging Integrated Solution Past Earnings Performance
Past criteria checks 0/6
Medimaging Integrated Solution's earnings have been declining at an average annual rate of -1.4%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 7.3% per year.
Key information
-1.4%
Earnings growth rate
-5.2%
EPS growth rate
Medical Equipment Industry Growth | 11.5% |
Revenue growth rate | 7.3% |
Return on equity | -2.1% |
Net Margin | -3.1% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Medimaging Integrated Solution makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 474 | -15 | 97 | 134 |
30 Jun 24 | 492 | 25 | 96 | 135 |
31 Mar 24 | 512 | 51 | 95 | 135 |
31 Dec 23 | 537 | 74 | 89 | 127 |
30 Sep 23 | 539 | 75 | 84 | 131 |
30 Jun 23 | 538 | 81 | 76 | 125 |
31 Mar 23 | 511 | 69 | 71 | 123 |
31 Dec 22 | 502 | 70 | 69 | 126 |
30 Sep 22 | 516 | 80 | 69 | 127 |
30 Jun 22 | 516 | 72 | 69 | 121 |
31 Mar 22 | 511 | 72 | 66 | 118 |
31 Dec 21 | 486 | 66 | 62 | 108 |
30 Sep 21 | 450 | 63 | 59 | 104 |
30 Jun 21 | 432 | 63 | 55 | 101 |
31 Mar 21 | 406 | 55 | 53 | 100 |
31 Dec 20 | 402 | 54 | 54 | 101 |
31 Dec 19 | 315 | 5 | 65 | 104 |
31 Dec 18 | 368 | 59 | 72 | 77 |
Quality Earnings: 6796 is currently unprofitable.
Growing Profit Margin: 6796 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6796 is unprofitable, and losses have increased over the past 5 years at a rate of 1.4% per year.
Accelerating Growth: Unable to compare 6796's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6796 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).
Return on Equity
High ROE: 6796 has a negative Return on Equity (-2.08%), as it is currently unprofitable.